Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
10.82
-0.01 (-0.05%)
Apr 13, 2026, 12:06 PM EDT - Market open
Arvinas Market Cap
Arvinas has a market cap or net worth of $691.74 million as of April 13, 2026. Its market cap has increased by 26.52% in one year.
Market Cap
691.74M
Enterprise Value
15.56M
1-Year Change
26.52%
Ranking
Category
Stock Price
$10.82
Market Cap Chart
Since September 27, 2018, Arvinas's market cap has increased from $516.15M to $691.74M, an increase of 34.02%. That is a compound annual growth rate of 3.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 692.06M | -9.14% |
| Dec 31, 2025 | 761.70M | -42.17% |
| Dec 31, 2024 | 1.32B | -52.94% |
| Dec 29, 2023 | 2.80B | 53.71% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 6.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Design Therapeutics | 749.93M |
| MeiraGTx Holdings | 730.57M |
| Lexicon Pharmaceuticals | 728.73M |
| Alto Neuroscience | 727.72M |
| Tenax Therapeutics | 725.58M |
| SpyGlass Pharma | 693.60M |
| Gyre Therapeutics | 674.81M |
| BridgeBio Oncology Therapeutics | 672.28M |